陳 虹如

Medicine & Life Sciences

1. Microglia 100%
2. Brain Injuries 77%
3. Stroke 65%
4. Monocytes 60%
5. X-Linked Creatine Deficiency 60%
6. creatine transporter 56%
7. Brain 48%
8. Brain Hypoxia 41%
9. Neurons 41%
10. Genomic Instability 40%
11. Hypoxia-Inducible Factor 1 40%
12. N-((1-(cyclopropylethyl)-6-fluoro-4-hydroxy-2-oxo-1,2-dihydro-3-quinolinyl)carbonyl)glycine 38%
13. Plasminogen Activators 37%
14. Cyclin-Dependent Kinases 37%
15. beta-Thalassemia 36%
16. Neurogenesis 33%
17. Creatine 32%
18. Zebrafish 32%
19. Adenosine Triphosphatases 31%
20. Copper 31%
21. Cyclin-Dependent Kinase 5 31%
22. Cerebral Cortex 29%
23. Embryonic Development 29%
24. Hypoxia 28%
25. DNA Damage 27%
26. Homeostasis 27%
27. Genes 26%
28. Maintenance 24%
29. Ischemia 23%
30. Rose Bengal 22%
31. Tamoxifen 20%
32. Blood Vessels 20%
33. Mothers 18%
34. Embryonic Structures 17%
35. Purines 17%
36. Prolyl Hydroxylases 16%
37. Brain Hypoxia-Ischemia 16%
38. CDC2 Protein Kinase 15%
39. Infarction 14%
40. Messenger RNA 14%
41. Macrophages 13%
42. Prolyl-Hydroxylase Inhibitors 13%
43. Proteins 12%
44. Neuronal Outgrowth 12%
45. Neurites 11%
46. Stem Cells 11%
47. Microarray Analysis 10%
48. Blood Platelets 10%
49. Knockout Mice 9%
50. In Situ Hybridization 9%